Abstract
Neurodegenerative disorders represent clusters of serious diseases that results in progressive deterioration of normal structure and physiology of central nervous system. Pathophysiology of Alzheimer’s, Parkinson’s or other neurodegenerative disorders involves multifaceted permutation of genetic and environmental factors. Combinations of lifestyle modification linked with environmental factor jointly or alone represent the largest share of cases of these disorders. Etiology of such neuronal degeneration involves manifestation of toxic reaction in the form of functional anomalies leading to dysfunction of the ubiquitin–proteasome system, activated inflammatory cascade, compromised neuronal survival pathway, mitochondrial dysfunction and finally neuronal apoptosis/necrosis and cell death. Furthermore, evidences from various studies exhibited role of oxidative stress and compromised anti-oxidant defense system as one of the prime factors associated with activation of various signal transduction pathways that would ultimately lead to the formation of amyloid beta or alpha synuclein in the brain. Keeping in view of complex etiology and pathophysiology along with a miniscule of available treatment options associated with these neurodegenerative disorders, the role of natural agents and herbal extracts as therapeutic alternatives alone or in combination with synthetic drugs could not be ruled out. In the same context the present chapter has been aimed to investigate the role of selected natural plants like Withania somnifera, Bacopa monnieri, Curcuma longa, Centella asiatica, Ocimum sanctum, Nardostachys jatamansi and Emblica officinalis in various neurodegenerative disorders and explore their targets to ameliorate neurotoxicity in various experimental models. The rationale for selection of these plants was based on their strong anti-inflammatory and anti-oxidant potential and large body of evidence that suggest their efficacy in preclinical as well as in clinical studies. Active constituents if these herbals might play an important role in preserving the integrity of various neurotransmitters and their receptor in the brain influencing its functions at the molecular level.
Keywords
- Herbal agents
- Neurotoxicity
- Alzheimer’s disease
- Parkinson’s disease
- Neurodegeneration
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-3-319-28383-8_24
This is a preview of subscription content, access via your institution.
Buying options
References
Adachi K, Yimen Y, Satake K, Matsuyama Y, Ishiguro N, Sawada M, Hirata Y, Kiuchi K. Localization of cyclooxygenase-2 induced following traumatic spinal cord injury. J Neurosci Res. 2005;51:73–80.
Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci. 2004;24(2):565–75.
Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age old spice with modern targets. Trends Pharmacol Sci. 2009;30(2):85–94.
Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16(4):313–26.
Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yousuf S, Hoda MN, Islam F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol. 2005;24(3):137–47.
Ahmad M, Yousuf S, Khan BM. Attenuation by Nardostachys jatamansi of 6 hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacol Biochem Behav. 2006;83(1):150–60.
Anand A, Saraf MK, Prabhakar S. Antiamnesic effect of B. monniera on L-NNA induced amnesia involves calmodulin. Neurochem Res. 2010;35(8):1172–81.
Anbarsi K, et al. Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats. Life Sci. 2006;78:12.
Anila L, Vijayalakshmi NR. J Ethnopharmacol. 2002;79:81–7.
Atta-ur-Rahman, Jamal AS, Choudary MI, Asif I. Two withanolides from Withania somnifera. Phytochemistry. 1991;30:3824–5.
Atta-ur-Rahman, Abbas S, Dur-e-Shawar, Jamal AS, Choudhary MI. New withanolides from Withania spp. J Nat Prod. 1993;56:1000–6.
Baltazar MT, Dinis-Oliveira RJ, de Lourdes BM, Tsatsakis AM, Duarte JA, Carvalho F. Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases--a mechanistic approach. Toxicol Lett. 2014;230(2):85–103.
Balanehru S, Nagarajan B. Intervention of adriamycin induced radical damage. Biochem Int. 1992;28:735–44.
Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res. 2000a;14:174–9.
Bhattacharya SK, Kumar A, Ghosal S. Effect of Bacopa monniera on animal models of Alzheimer’s disease and perturbed central cholinergic markers of cognition in rats. In: Siva Sankar DV, editor. Molecular aspects of Asian medicines. New York: PJD; 2000b.
Bhattacharya SK, Bhattacharya D, Sairam K, Ghosal S. Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia. Phytomedicine. 2002;9:167–70.
Bigford GE, Del Rossi G. Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders. Adv Nutr. 2014;5(4):394–403.
Bishnoi M, Chopra K, Kulkarni SK. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav. 2008;88(4):511–22.
Bollimpelli VS, Kumar P, Kumari S, Kondapi AK. Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity. Neurochem Int. 2016;95:37–45. doi:10.1016/j.neuint.2016.01.006.
Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361:31–9.
Chakravarty AK, Sarkar T, Masuda K, Shiojima K, Nakane T, Kawahara N. Bacopa side I and II: two pseudojujubogenin glycosides from Bacopa monniera. Phytochemistry. 2001;58:553–6.
Chakravarty AK, Garai S, Masuda K, Nakane T, Kawahara N. Bacopasides III–V: three new triterpenoid glycosides from Bacopa monniera. Chem Pharm Bull. 2003;51:215–7.
Chan PH, Fishman RA, Wesley MA, Longar S. Pathogenesis of vasogenic edema in focal cerebral ischemia. Role of superoxide radicals. Adv Neurol. 1990;52:177–83.
Chan S, Kantham S, Rao VM, Palanivelu MK, Pham HL, Shaw PN, McGeary RP, Ross BP. Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer's disease. Food Chem. 2016;199:185–94.
Chatterjee A, Basak B, Saha M, et al. Structure and stereo-chemistry of Nardostachysin, a new terpenoid ester constituent of the rhizomes of Nardostachys Jatamansi. J Nat Prod. 2000;63(11):1531–3.
Chatterji A, Prakashi SC. The treatise on Indian medicinal plants, vol 5. New Delhi: National Institute of Science Communication (Publication and Information Directorate); 1997.
Chaudhary G, Sharma U, Jagannathan NR, Gupta YK. Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol. 2003;30(5–6):399–404.
Cheng CL, Guo JS, Luk J, Koo MWL. The healing effects of Centella extract and asiaticoside on acetic acid induced gastric ulcers in rats. Life Sci. 2004;74:2237–49.
Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261–76.
Choudary MI, Abbas S, Jamal AS, Atta-ur-Rahman. Withania somnifera—a source of exotic withanolides. Heterocycles. 1996;42:555–63.
Choudhary MI, Yousuf S, Nawaz SA, Ahmed S. Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull (Tokyo). 2004;52(11):1358–61.
Cui Q, Li X, Zhu H. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway. Mol Med Rep. 2016;13(2):1381–8.
Das A, Shanker G, Nath C, Pal R, Singh S, Singh H. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba: anticholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav. 2002;73:893–900.
De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem. 2007;282(15):11590–601.
Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, Young KA, Manyam BV. Centella asiatica extract selectively decreases amyloid β levels in hippocampus of Alzheimer’s disease animal model. Phytother Res. 2009;23:14–9.
Dhawan BN, Singh HK. Pharmacology of ayurvedic nootropic Bacopa monniera, Abstr. No. NR 59. Int Conv Biol Psychiat. Bombay; 1996.
Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G. Curcumin--from molecule to biological function. Angew Chem Int Ed Engl. 2012;51(22):5308–32.
Fu W, Zhuang W, Zhou S, Wang X. Plant-derived neuroprotective agents in Parkinson's disease. Am J Transl Res. 2015;7(7):1189–202.
Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem. 2007;102:1095–104.
Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem Toxicol. 2015;83:111–24.
Gim SA, Lee SR, Shah FA, Koh PO. Curcumin attenuates the middle cerebral artery occlusion-induced reduction in γ-enolase expression in an animal model. Lab Anim Res. 2015;31(4):198–203.
Ghosal S, Tripathi VK, Chauhan S. Active constituents of Emblica officinalis: part 1—the chemistry and antioxidant effects of two new hydrolysable tannins, emblicanin A and B. Indian J Chem. 1996;35B:941–8.
Gnanapragasam A, Kumar Ebenezar K, Sathish V, Govindaraju P, Devaki T. Protective effect of Centella asiatica on antioxidant tissue defense system against adriamycin induced cardiomyopathy in rats. Life Sci. 2004;76:585–97.
Grace EA, Rabiner CA, Busciglio J. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience. 2002;114(1):265–73.
Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and Ginseng. J Ethnopharmacol. 1994;44(3):131–5.
Gruart A, Munoz MD, Delgado-Garcia JM. Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice. J Neurosci. 2006;26:1077–87.
Hakkim FL, Shankar CG, Girija S. Chemical composition and antioxidant property of holy basil (Ocimum sanctum L.) leaves, stems, and inflorescence and their in vitro callus cultures. J Agric Food Chem. 2007;55(22):9109–17. Epub 2007 Oct 9.
Haleagrahara N, Ponnusamy K. Neuroprotective effect of centialla asiatica extract on experimentally induced Parkinsonism in aged Sprague-Dawley rats. J Toxicol Sci. 2010;35(1):41–7.
Handa SS, Deepak M, Mangal AK. Centella asiatica. Indian herbal pharmacopoeia. Indian drug manufacturer. Jammu-Tawi, India: Mumbai and Regional Res. Lab; 1988. p. 47–55.
Harney SC, Rowan M, Anwyl R. Long-term depression of NMDA receptor-mediated synaptic transmission is dependent on activation of metabotropic glutamate receptors and is altered to long-term potentiation by low intracellular calcium buffering. J Neurosci. 2006;26:1128–32.
Hosamani R. Muralidhara. Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster. Neurotoxicology. 2009;30(6):977–85.
Hosamani R. Muralidhara. Prophylactic treatment with Bacopa monnieri leaf powder mitigates paraquat-induced oxidative perturbations and lethality in Drosophila melanogaster. Indian J Biochem Biophys. 2010;47(2):75–82.
Hou CC, Lin SJ, Cheng JT, Hsu FL. Bacopaside III, bacopasaponin G, and bacopasides A, B, and C from Bacopa monniera. J Nat Prod. 2002;65:1759–63.
Jadiya P, Khan A, Sammi SR, Kaur S, Mir SS, Nazir A. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease. Biochem Biophys Res Commun. 2011;413:605–10.
Jew SS, Yoo CH, Lim DY, Kim H, Mook-Jung I, Jung MW, Choi H, Jung YH, Kim H, Park HG. Structure–activity relationship study of asiatic acid derivatives against beta amyloid (A beta)-induced neurotoxicity. Bioorg Med Chem Lett. 2000;10:119–21.
Joshi H, Parle M. Nardostachys jatamansi improves learning and memory in mice. J Med Food. 2006;9(1):113–8.
Justin Thenmozhi A, Dhivyabharathi M, William Raja TR, Manivasagam T, Mohamed EM. Tannoid principles of Emblica officinalis renovate cognitive deficits and attenuate amyloid pathologies against aluminum chloride induced rat model of Alzheimer's disease. Nutr Neurosci. 2016;19:269–78 [Epub ahead of print].
Khattak S, Saeed-Ur-Rehman, Shah HU, Khan T, Ahmad M. In vitro enzyme inhibition activities of crude ethanolic extracts derived from medicinal plants of Pakistan. Nat Prod Res. 2005;19(6):567–71.
Krishnamurthy RG, Senut M-C, Zemke D, Min J, Frenkel MB, Greenberg EJ, Yu S-W, Ahn N, Goudreau J, Kassab M, Panickar KS, Majid A. Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. J Neurosci Res. 2009;87(11):2541–50.
Kritikar KR, Basu BD. Indian medicinal plants. 2nd ed. New Delhi: Periodical Export; 1991. p. 488–90.
Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)-induced neurodegeneration. Eur J Neurol. 2006;23(6):1417–26.
Kulkarni SK, Dhir A. Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1093–105.
Kumar VP, Chauhan NS, Padh H, Rajani M. Search for antibacterial and antifungal agents from selected Indian, medicinal plants. J Ethnopharmacol. 2006;107:182.
Kumar A, Dogra S, Prakash A. Neuroprotective effects of Centella asiatica against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress. Int J Alzheimer’s Dis. 2009;2009:972178.
Langston JW. The impact of MPTP on Parkinson’s disease research: past, present, and future. In: Factor SA, Weiner WJ, editors. Parkinson’s disease. Diagnosis and clinical management. New York: Demos Medical Publishing; 2002.
Lanni C, Lenzken SC, Pascal A. Pharmacol Res. 2008;57:196–213.
Le XT, Nguyet Pham HT, Van Nguyen T, Minh Nguyen K, Tanaka K, Fujiwara H, Matsumoto K. Protective effects of Bacopa monnieri on ischemia-induced cognitive deficits in mice: the possible contribution of bacopaside I and underlying mechanism. J Ethnopharmacol. 2015;164:37–45.
Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21:8370–7.
Limpeanchob N, Jaipan S, Rattanakaruna S, Phrompittayarat W, Ingkaninan K. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J Ethnopharmacol. 2008;120(1):112–7.
Liu L, Zhang W, Wang L, Li Y, Tan B, Lu X, Deng Y, Zhang Y, Guo X, Mu J, Yu G. Curcumin prevents cerebral ischemia reperfusion injury via increase of mitochondrial biogenesis. Neurochem Res. 2014;39(7):1322–31.
Li X, Zuo P. Effects of Aβ 25−35 on neurogenesis in the adult mouse subventricular zone and dentate gyrus. Neurol Res. 2005;27:218–22.
Luo GR, Le WD. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases. Curr Pharm Biotechnol. 2010;11(2):180–7.
Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009;14(7):2373–93.
Murthy PB, Raju VR, Ramakrisana T, Chakravarthy MS, Kumar KV, Kannababu S, Subbaraju GV. Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem Pharm Bull (Tokyo). 2006;54(6):907–11.
Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, et al. Functional organization of the basal ganglia: therapeutic implications for Parkinson’s disease. Mov Disord. 2008;23 Suppl 3:S548–59.
Ono K, Hasegawa K, Naiki H, Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro. J Neurosci Res. 2004;75:742–50.
Parrón T, Requena M, Hernández AF, Alarcón R. Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol Appl Pharmacol. 2011;256(3):379–85.
Perry VH, Newman TA, Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci. 2003;4:103–12.
Prabhakar S, Saraf MK, Pandhi P, Anand A. Bacopa monniera exerts antiamnesic effect on diazepam-induced anterograde amnesia in mice. Psychopharmacology. 2008;200:27–37.
Rajasankar S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, Krishnamurti A, Surendran S. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson’s disease model mouse. J Ethnopharmacol. 2009a;125(3):369–73. Epub 2009 Aug 8.
Rajasankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease. Neurosci Lett. 2009b;454(1):11–5.
Rajeswari A. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur Rev Med Pharmacol Sci. 2006;10:157–61.
Rathore P, Dohare P, Varma S, Ray A, Sharna U, Jaganathanan NR, Ray M. Curcuma Oil: reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain. Neurochem Res. 2008;33(9):1672–82.
Rastogi S, Pal R, Kulshreshtha DK. Bacoside A3-a triterpenoid saponin from Bacopa monniera. Phytochemistry. 1994;36:133–7.
Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443(7113):780–6.
Russo F, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005;12:305–17.
Sankar SR, Manivasagam T, Krishnamurti A, Ramanathan M. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol Biol Lett. 2007;12(4):473–81.
Salim S, Ahmad M, Zafar KS, Ahmad AS, Islam F. Protective effect of Nardostachys jatamansi in rat cerebral ischemia. Pharmacol Biochem Behav. 2003;74(2):481–6.
Samson J, Sheeladevi R, Ravindran R. Oxidative stress in brain and antioxidant activity of Ocimum sanctum in noise exposure. Neurotoxicology. 2007;28(3):679–85.
Saraf MK, Anand A, Prabhakar S. Scopolamine induced amnesia is reversed by Bacopa monniera through participation of kinase-CREB pathway. Neurochem Res. 2010;35:279–87.
Selkoe DJ. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis. 2001;3(1):75–80.
Shukla PK, Khanna VK, Ali MM, Khan MY, Srimal RC. Anti-ischemic Effect of Curcumin in Rat Brain. Neurochem Res. 2008;33:1036–43.
Sembulingam K, Sembulingam P, Namasivayam A. Effect of Ocimum sanctum Linn on the changes in central cholinergic system induced by acute noise stress. J Ethnopharmacol. 2005;96:477–82.
Shinomol GK, Ravikumar H, Muralidhara. Prophylaxis with Centella asiatica confers protection to prepubertal mice against 3-nitropropionic-acid-induced oxidative stress in brain. Phytother Res. 2010;24:885–92.
Singh MK, Yadav SS, Yadav RS, Chauhan A, Katiyar D, Khattri S. Protective effect of Emblica-officinalis in arsenic induced biochemical alteration and inflammation in mice. Springerplus. 2015;4:438.
Singh HK, Srimal RC, Srivastava AK, Garg NK, Dhan BN. Neuropsychopharmacological effects of bacosides A and B. Proceedings of the Fourth Conference on Neurobiology Learning Memory, 1990; Abstract No. 79. Irvine California.
Singh M, Murthy V, Ramassamy C. Standardized extracts of Bacopa monniera protect against MPP+− and paraquat-induced toxicity by modulating mitochondrial activities, proteasomal functions, and redox pathways. Toxicol Sci. 2012;125(1):219–32.
Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia, part 11: mechanisms of damage and treatment. J Neurosurg. 1992;77:337–54.
Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta. 2009;1802(1):80–91.
Singh HK, Dhawan BN. Drugs affecting learning and memory. In: Tandon PN, Bijiani V, Wadhwa S, editors. Lectures in neurobiology, vol. 1. New Delhi: Wiley Eastern; 1992. p. 189–207.
Song S, Nie Q, Li Z, Du G. Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats. Pathol Res Pract. 2016;212(4):247–51.
Srivastava P, Yadav RS, Chandravanshi LP, Shukla RK, Dhuriya YK, Chauhan LK, Dwivedi HN, Pant AB, Khanna VK. Unraveling the mechanism of neuroprotection of curcumin in arsenic induced cholinergic dysfunctions in rats. Toxicol Appl Pharmacol. 2014;279(3):428–40.
Strimpakos AS, Sharma RA. Curcumin: Preventive and Therapeutic properties in laboratory studies and clinical trials. Antioxidant Redox Signaling. 2008;10(3):511–45.
Subathra M, Shila S, Devi MA, Panneerselvam C. Emerging role of Centella asiatica in improving age-related neurological antioxidant status. Exp Gerontol. 2005;40:707–15.
Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004;74:969–85.
Tohda C, Tamura T, Komatsu K. Repair of amyloid β(25–35)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to. Brain Res. 2003;990:141–7.
Tohda C, Matsumoto N, Zou K, Meselhy RM, Komatsu K. Aβ(25–35)-induced memory impairment, axonal atrophy and synaptic loss are ameliorated by M1, a metabolite of protopanaxadiol-type saponins. Neuropsycopharmacology. 2004;29:860–8.
Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP. Bacopa monniera Linn. as an antioxidant: mechanism of action. Indian J Exp Biol. 1996;34:523–6.
Tupe RS, Sankhe NM, Shaikh SA, Phatak DV, Parikh JU, Khaire AA, Kemse NG. Aqueous extract of some indigenous medicinal plants inhibits glycation at multiple stages and protects erythrocytes from oxidative damage-an in vitro study. J Food Sci Technol. 2015;52(4):1911–23.
Tully T, Bourtchouladze R, Scott R. Nat Rev Drug Discov. 2003;2:266–77.
Udupa KN, Singh RH. Clinical and experimental studies on rasayana drugs and panchkarma therapy. New Delhi: Central Council for Research in Ayurveda and Siddha; 1995.
Vasudevan M, Parle M. Memory enhancing activity of Anwala churna (Emblica officinalis Gaertn.): an Ayurvedic preparation. Physiol Behav. 2007;16:91.
Veerendra Kumar MH, Gupta YK. Effect of different extracts of Centella asiatica on cognition and markers of oxidative stress in rats. J Ethnopharmacol. 2002;79:253–60.
Vinutha JP. Acetyl cholinesterase inhibitory activity of methanolic and successive water extracts of Nardostachys jatamansi. Indian J Pharmacol. 2007;23:127–31.
Vinutha B, Prashanth D, Salma K, Sreeja SL, Pratiti D, Padmaja R, Radhika S, Amit A, Venkateshwarlu K, Deepak M. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J Ethnopharmacol. 2007;109(2):359–63.
Wang Q, Sun AY, Simonyi A, Jensen MD, et al. Neuroprotective mechanisms of curcumin against cerebral ischemiainduced neuronal apoptosis and behavioral deficits. J Neurosci Res. 2005;82:138–48.
Yadav RS, Sankhwar ML, Shukla RK, Chandra R, Pant AB, Islam F, Khanna VK. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol Appl Pharmacol. 2009;240(3):367–76.
Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo. J Biol Chem. 2005;280:5892–901.
Zhang YJ, Tanak T, Iwamoto Y, Yang CR, Kouno I. J Nat Prod. 2000;63:1507–10.
Zheng CJ, Qin LP. Chemical components of Centella asiatica and their bioactivities. J Chin Integr Med. 2007;5(3):348–51.
Compliance with Ethics Requirements
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Srivastava, P., Yadav, R.S. (2016). Efficacy of Natural Compounds in Neurodegenerative Disorders. In: Essa, M., Akbar, M., Guillemin, G. (eds) The Benefits of Natural Products for Neurodegenerative Diseases. Advances in Neurobiology, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-28383-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-28383-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28381-4
Online ISBN: 978-3-319-28383-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)